Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Satishkumar P. Jain"'
Publikováno v:
Drug Development and Industrial Pharmacy. 36:1364-1376
Microcrystalline cellulose (MCC) is the most widely used extrusion-spheronization aid but is associated with several limitations such as adsorption of actives, longer dissolution time, and degradation of some sensitive drugs such as ranitidine.This a
Publikováno v:
AAPS PharmSciTech. 11:936-944
The present paper was focused on exploiting Plackett-Burman design to screen the effect of nine factors--poly (ethylene oxide) molecular weight (X(1)), poly (ethylene oxide) amount (X(2)), ethylcellulose amount (X(4)), drug solubility (X(5)), drug am
Publikováno v:
AAPS PharmSciTech. 11:917-923
Microcrystalline cellulose (MCC) is well established as an extrusion spheronisation aid for the preparation of pellets. Crospovidone (Polyplasdone® XL-10) is compared with microcrystalline cellulose for the preparation of melt-in-mouth pellets. Tast
Publikováno v:
Chromatographia. 69:385-388
This paper discusses the development of a stability-indicating reversed-phase LC method for analysis of cholecalciferol as the bulk drug and in formulations. The mobile phase was acetonitrile–methanol–water 50:50:2 (v/v). The calibration plot for
Autor:
Sejal Shah, Namita Sham Rajadhyaksha, Pirthi Pal Singh P S, Purnima D. Amin, Satishkumar P. Jain
Publikováno v:
Drug Development and Industrial Pharmacy. 34:445-452
This article focuses on preparation and evaluation of a once a day ophthalmic delivery system for ciprofloxacin hydrochloride based on the concept of pH-triggered in situ gelation. The in situ gelling system involves the use of polyacrylic acid (Carb
Autor:
Leena Rao, Satishkumar P. Jain, Ajit S. Marathe, Namita B Prabhu, Kiran P. Sawant, Pirthi Pal Singh, Purnima D. Amin
In vitro dissolution specifications are established to ensure batch-to-batch consistency while pointing out any potential problems with in vivo bioavailability among different drug products (1). At early stages of formulation development, in vitro di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645f02cce99025df3facb6b9983750b5
https://europepmc.org/articles/PMC2977020/
https://europepmc.org/articles/PMC2977020/
Publikováno v:
Indian Journal of Pharmaceutical Sciences
Trimetazidine dihydrochloride, a cellular antiischemic agent indicated in the management and prophylaxis of angina pectoris is given as 20 mg thrice daily in the conventional dosage regimen. The purpose of the present study was to formulate and evalu